BREAKING: Market Rally Gains Steam As These Hopes Rise
One of the three positive chart patterns to look for when doing technical analysis of a stock. This pattern looks like the letter W, but in almost all cases, the second leg down should undercut the low price of the first.
Centene (CNC) is Friday's IBD Stock Of The Day as it stands up well against the volatile market. CNC stock is regaining technical support within a valid base.
The St. Louis-based company is one of the largest Medicaid-based managed care organizations in the country. While Centene primarily provides health care products and services through Medicaid and Medicare, it also works through private insurers.
CNC and other managed care providers have been mounting a rally this week amid a market that has been rocked by fears of a recession.
CNC stock closed down 0.9% to 82.91 in Friday's market trading. The stock is above its 50-day moving average and has formed a double-bottom base with an 87.44 buy point, according to MarketSmith analysis. If Centene manages to get above its high from Thursday high, around 84, it would break a downward sloping trendline. That would provide aggressive investors an early entry around that 84 level.
CNC peer UnitedHealth (UNH) is also in a double-bottom base . The buy point on that base is 507.35. This competing health insurance giant was Thursday's IBD's Stock Of The Day.
Centene beat Wall Street's first-quarter predictions with revenue increasing 24% year over year. Analysts predict that CNC earnings per share will increase 8% in 2022 and that revenue will edge up 13%, according to FactSet.
Last week, Centene increased its 2022 full-year guidance. The company cited increased Medicaid premium revenue and "favorable" insurance marketplace performance so far in the second-quarter as reasons for the guidance increase.
Funds and other institutional investors own 67% of Centene's outstanding shares. As of March, 2,269 funds owned CNC shares, an increase of 124 since December, according to MarketSmith.
Centene has a 97 Composite Rating, a key IBD benchmark. It has a 94 Relative Strength Rating, an exclusive IBD Stock Checkup measurement for share price movement with a top grade of 99. The rating shows how a stock's performance over the last 52 weeks holds up against all the other stocks in IBD's database. The EPS rating is 93.
Please follow Kit Norton on Twitter @KitNorton for more coverage.
Top Funds Buy Into No. 1 Industry Leader Near Breakout With 364% Growth
Get An Edge In The Stock Market With IBD Digital
Best Growth Stocks To Buy And Watch
Warren Buffett EV Play BYD Races Higher, Takes On Tesla
Market Rally Gains Steam; What To Do Now
6:35 AM ET Looking for the best stocks to buy and watch? Start by checking IBD Stock Of The Day for quick highlights...
6:35 AM ET Looking for the best stocks to buy and watch? Start...
Wiping out Bitcoin's gains over the past 4.5 years is challenging the notion that long-term holders can't lose. (© maxtrks28/stock.adobe.com)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor's Business Daily, LLC. All rights reserved